Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature
暂无分享,去创建一个
D. Busch | D. Haller | K. Janssen | M. Gerhard | S. Jarosch | R. Mejías-Luque | M. Middelhoff | Li Deng | A. Wanisch | Michael Vieth | V. Engelsberger | Anna Ralser | Alisa Dietl | M. Quante | M. Vieth | Michael Quante | Dirk Haller | K. Janssen | Dirk H Busch | L. Deng | Michael Vieth | Markus | Gerhard
[1] T. Shimoyama,et al. Impact of Helicobacter pylori infection on gut microbiota , 2021, World journal of gastroenterology.
[2] M. Kazemian,et al. TCF-1 controls Treg functions that regulate inflammation, CD8 T-cell cytotoxicity, and severity of colon cancer. , 2021, Nature Immunology.
[3] E. El-Omar,et al. The interplay between Helicobacter pylori and gastrointestinal microbiota , 2021, Gut microbes.
[4] C. Trautwein,et al. The gut bacterium Extibacter muris produces secondary bile acids and influences liver physiology in gnotobiotic mice , 2020, Gut microbes.
[5] Lijuan Wang,et al. A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8+ T cells in mice , 2020, Gut.
[6] M. Vieth,et al. Effect of Helicobacter pylori on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer , 2019, Gut.
[7] F. Franceschi,et al. Review: Helicobacter pylori and extragastric diseases , 2019, Helicobacter.
[8] Paul Theodor Pyl,et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer , 2019, Nature Medicine.
[9] N. Ashley,et al. Colonic epithelial cell diversity in health and inflammatory bowel disease , 2019, Nature.
[10] Lai Guan Ng,et al. Dimensionality reduction for visualizing single-cell data using UMAP , 2018, Nature Biotechnology.
[11] Yu Chen,et al. Loss of adenomatous polyposis coli function renders intestinal epithelial cells resistant to the cytokine IL-22 , 2018, bioRxiv.
[12] M. Romano,et al. Helicobacter pylori and extragastric diseases: A review , 2018, World journal of gastroenterology.
[13] Erik Sundström,et al. RNA velocity of single cells , 2018, Nature.
[14] S. Itzkovitz,et al. Spatial Reconstruction of Single Enterocytes Uncovers Broad Zonation along the Intestinal Villus Axis , 2018, Cell.
[15] Ricardo J. Miragaia,et al. Single-Cell Transcriptomics of Regulatory T Cells Reveals Trajectories of Tissue Adaptation , 2019, Immunity.
[16] W. Shi,et al. The TNF Receptor Superfamily-NF-κB Axis Is Critical to Maintain Effector Regulatory T Cells in Lymphoid and Non-lymphoid Tissues. , 2017, Cell reports.
[17] D. Chang,et al. Helicobacter pylori infection is an independent risk factor of early and advanced colorectal neoplasm , 2017, Helicobacter.
[18] B. Becher,et al. Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal Inflammation. , 2016, Cell reports.
[19] M. Vieth,et al. Lymphotoxin β receptor signalling executes Helicobacter pylori-driven gastric inflammation in a T4SS-dependent manner , 2016, Gut.
[20] M. Blaser,et al. Gastric Helicobacter pylori Infection Affects Local and Distant Microbial Populations and Host Responses. , 2016, Cell reports.
[21] A. Giraud,et al. STAT3: a critical component in the response to Helicobacter pylori infection , 2015, Cellular microbiology.
[22] D. Voehringer,et al. The microbiota regulates type 2 immunity through RORγt+ T cells , 2015, Science.
[23] M. Neurath,et al. Mechanisms of Immune Signaling in Colitis-Associated Cancer , 2014, Cellular and molecular gastroenterology and hepatology.
[24] Antonio Gasbarrini,et al. Helicobacter pylori and Extragastric Diseases , 2014, Helicobacter.
[25] Hui Li,et al. IL‐17+Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cells , 2014, Journal of leukocyte biology.
[26] D. Pardoll,et al. Stat3 Activation in Murine Colitis Induced by Enterotoxigenic Bacteroides fragilis , 2014, Inflammatory bowel diseases.
[27] C. Prinz,et al. Helicobacter pylori Cytotoxin-Associated Gene A Impairs Human Dendritic Cell Maturation and Function through IL-10–Mediated Activation of STAT3 , 2014, The Journal of Immunology.
[28] Andrew V. Nguyen,et al. STAT3 in epithelial cells regulates inflammation and tumor progression to malignant state in colon. , 2013, Neoplasia.
[29] Amy M. Sheflin,et al. Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy Adults , 2013, PloS one.
[30] S. Reuter,et al. Helicobacter pylori γ-glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance , 2013, Proceedings of the National Academy of Sciences.
[31] H. Clevers,et al. Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties , 2013, Cell.
[32] S. Pettersson,et al. Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice. , 2012, Carcinogenesis.
[33] S. Reuter,et al. DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. , 2012, The Journal of clinical investigation.
[34] A. Saito,et al. The Endoplasmic Reticulum Stress Transducer OASIS Is involved in the Terminal Differentiation of Goblet Cells in the Large Intestine* , 2012, The Journal of Biological Chemistry.
[35] G. Nardone,et al. Contribution of Gut Microbiota to Colonic and Extracolonic Cancer Development , 2011, Digestive Diseases.
[36] Sebastian Reuter,et al. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. , 2011, The Journal of clinical investigation.
[37] C. Ma,et al. Colorectal Cancer–Derived Foxp3+IL‐17+ T Cells Suppress Tumour‐Specific CD8+ T Cells , 2011, Scandinavian journal of immunology.
[38] J. Galon,et al. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. , 2011, Cancer research.
[39] Benyan Wu,et al. Foxp3+IL‐17+ T cells promote development of cancer‐initiating cells in colorectal cancer , 2011, Journal of leukocyte biology.
[40] T. Wang,et al. Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. , 2011, Gastroenterology.
[41] R. Flavell,et al. Helicobacter pylori-Induced Th17 Responses Modulate Th1 Cell Responses, Benefit Bacterial Growth, and Contribute to Pathology in Mice , 2010, The Journal of Immunology.
[42] Mark J. Miller,et al. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. , 2010, Gastroenterology.
[43] E. Casanova,et al. Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice. , 2010, Gastroenterology.
[44] D. Sargent,et al. Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma. , 2009, Gastroenterology.
[45] H. Herfarth,et al. Modulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer Susceptibility , 2009, PloS one.
[46] Ozge Canli,et al. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. , 2009, Cancer cell.
[47] A. Rizzo,et al. IL‐23‐mediated regulation of IL‐17 production in Helicobacter pylori‐infected gastric mucosa , 2008, European journal of immunology.
[48] C. Sasakawa,et al. Role of Peyer's patches in the induction of Helicobacter pylori-induced gastritis , 2007, Proceedings of the National Academy of Sciences.
[49] M. Katoh,et al. Notch signaling in gastrointestinal tract (review). , 2007, International journal of oncology.
[50] Miguel Abal,et al. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. , 2006, Gastroenterology.
[51] R. Fodde,et al. APC and Oncogenic KRAS Are Synergistic in Enhancing Wnt Signaling in Intestinal Tumor Formation and Progression , 2006 .
[52] Toshiyuki Nakayama,et al. Activation of STAT3 is a marker of poor prognosis in human colorectal cancer. , 2006, Oncology reports.
[53] S. Brandt,et al. NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[54] S. V. van Zanten,et al. Gastric Transitional Zones, Areas where Helicobacter Treatment Fails: Results of a Treatment Trial Using the Sydney Strain Mouse Model , 2003, Antimicrobial Agents and Chemotherapy.
[55] J. Coxhead,et al. Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[56] K. Abrams,et al. The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.
[57] R. Rappuoli,et al. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[58] M. Borodovsky,et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[59] B. Malomed,et al. A new form of liquid matter: Quantum droplets , 2020, Frontiers of Physics.